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Prevalence, awareness, treatment and control of hypertension in
the Palestinian population
MR Khdour1, HO Hallak1, M Shaeen2, AS Jarab3 and QN Al-Shahed4
We determined the prevalence of hypertension and the level of awareness, treatment and control of hypertension among
Palestinian adults in a population-based cross-sectional survey. Two-stage stratiﬁed sampling method was used to select 2077
participants from the general population aged 25 years and over. Trained observers obtained two blood pressure (BP)
measurements from each individual by the use of a standardized mercury sphygmomanometer after a 5-min sitting rest.
Information on sociogeographical factors and antihypertensive medications was obtained using a standard questionnaire.
Hypertension was deﬁned as a mean systolic BP (SBP)X140mm Hg, diastolic BP (DBP)X90mmHg, and/or use of antihypertensive
medications. The overall prevalence of hypertension was 27.6%, with a higher percentage among men (29.2 vs 26.4%; P¼ 0.04).
Hypertension increased with age in both men and women. Among hypertensive patients, 51.0% were aware of their elevated BP,
40.2% had treatment and only 9.5% achieved targeted BP control (o140/90mmHg). Patients under antihypertensive treatment
showed SBP and DBP that were only 3.1mmHg and 2.5mmHg lower than individuals without antihypertensive treatment,
respectively. The data show that hypertension prevalence among Palestinian adults is high, whereas the proportions of awareness
treatment and control of hypertension were low. Concerted public health effort is urgently required to improve the detection,
treatment and control of hypertension in Palestine.
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INTRODUCTION
Substantial socioeconomic and demographic changes have taken
place in countries of the Eastern Mediterranean region over the
past two decades. The population of this region has almost
doubled, more people are in older age, and the proportion of
urban population has been increasing.1–4
Several lines of evidence suggest that hypertension and its
complications are a major health problem in Palestine. First, the
incidence of blood pressure (BP)-related clinical events such as
myocardial infarction, stroke and end-stage renal disease appears
to be increasing dramatically. Vital statistics (such as cause-speciﬁc
mortality and hospitalization discharge diagnoses) along with
clinical observations support this notion.5 Second, preliminary
surveys suggest that the prevalence of hypertension may be as
high as 24%.6–9
To the best of our knowledge, this study is the ﬁrst to present
authentic nationwide current data about prevalence, awareness,
treatment and control of hypertension among adults in one
report. Two surveys of diabetes prevalence, one in a rural
community and the other in an urban community, were
conducted in 1996 and 1998, respectively;10,11 prevalence of
components of the metabolic Syndrome was studied in 2001.7
In 2011, the Palestinian Hypertension Project was initiated at
Al-Quds University. The Palestinian Hypertension Project is a joint
project between Al-Quds University and Palestinian Ministry of
Health, supported by Palestinian American Research Council. The
principal Palestinian Hypertension Project objectives are (1) to
estimate the magnitude of hypertension and its levels of
awareness, and control of hypertension in Palestinian adults;
(2) to identify environmental factors associated with high BP in
Palestine, and (3) to establish an infrastructure for research and
education in the prevention and treatment of hypertension, as
well as other cardiovascular disease risk factors.
The study herein addressed a number of issues that are relevant
to the scientiﬁc community, health-care providers and public
health in the West Bank, Palestine. These data included namely,
national estimates of the prevalence of hypertension, medical
utilization, status of hypertension awareness and control in the
general adult population.
MATERIALS AND METHODS
A cross-sectional survey was conducted across the West Bank, Palestine.
The West Bank, Palestine has a land area of 5640 km2 (including East
Jerusalem) and an estimated population of 2 274 929 according to the
ofﬁcial Palestinian census of 2011.12
Palestinian population is quite heterogenous in terms of its social class,
dietary habits and living area (urban versus rural). Such heterogeneity
within the Palestinian population underscores the need for surveying
representative samples of these groups, and lends itself well to the studies
that examine the effect of environmental risk factors on the presence of
hypertension and its complications.
Two Palestinian communities in the three main governorate, Nablus
(north), Ramallah (Center) and Hebron (south) of the West Bank, one rural
and one urban, were surveyed between May 2011 and December 2011.
Two-stage stratiﬁed sampling method was used to select a nationally
representative sample of the general population aged 25 years or over. The
sampling process was stratiﬁed by site and rural versus urban areas.
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Screening for hypertension was carried out at six governmental primary
clinics in people aged 25 or over, attending health clinics either as patients
or accompanying family members. The health clinics were randomly
selected according to their site. Each clinic represented a distinct region of
the country: Ramallah primary clinic (Urban, center), Der Qedies primary
clinic (Rural, center), Nablus primary clinic (Urban, north), Zababda primary
clinic (Rural, north), Hebron primary clinic (Urban, south) and Arab
el-ramadin (Rural, south). Eligibility was based on age (X25 years old), and
mental and physical ability to participate.
During clinic visits, trained research staff administered a standard
questionnaire. Information on demographic characteristics—including age,
gender, education, occupation and smoking status was collected. The
interview also included questions related to the diagnosis and treatment of
hypertension. Information on the awareness of and drug treatment and
lifestyle modiﬁcation for hypertension was obtained.
Two BP measurements were obtained from each participant by trained
and certiﬁed observers, according to a common protocol adapted from
procedures recommended by the American Heart Association.13 A
standardized mercury sphygmomanometer was used, and one of the
three cuff sizes (small, regular or large) was chosen on the basis of
the circumference of the participant’s arm.13 The cuff was placed on the
respondent’s right arm 2–3 cm above the antecubital fossa. Two BP
measurements were taken with an interval of 3min apart. Respondents
were informed of their BP measurements. During ﬁeld surveys, supervisors
conducted weekly checks on compliance with the BP measurement
protocol. Hypertension is deﬁned as an average systolic BP (SBP)
X140mmHg, an average diastolic BP (DBP) X90mmHg and/or self-
reported current treatment for hypertension with antihypertensive
medication. Awareness of hypertension is deﬁned as the self-report of
any prior diagnosis of hypertension by a health-care professional.
Treatment of hypertension is deﬁned as the use of a prescription
medication for management of high BP at the time of interview. Control
of hypertension is deﬁned as pharmacological treatment of hypertension
associated with an average SBPp140mmHg and DBPp90mmHg.14 The
distribution of BP levels based on categories established in the Sixth
Report of the Joint National Committee on detection, evaluation and
treatment of high BP,15 and WHO-International Society of Hypertension
Guidelines for the management of hypertension16 are presented. These
include six BP levels: optimal, normal, high normal, hypertensive grades 1,
2 and 3.
Data were analyzed using SPSS (version 18 for Windows; SPSS Inc,
Chicago, IL, USA). Chi-square statistic was used to test for independency of
the distribution of both the previously diagnosed and previously
undiagnosed hypertensives, and the distribution of both controlled and
uncontrolled hypertension among the various categories of study
variables. The level of signiﬁcance was set at P-value p0.05. Multiple
logistic regression analyses will be performed to test for the independent
effect of purported risk factors on hypertension.
RESULTS
Sample characteristics
Characteristics of the sample are summarized in Table 1. The
sample comprised 2077 participants, 58% were females subjects.
The response rate was 73% for men and 79% for women. A total
of 63.8% were from urban areas and the remaining 36.2% from
rural areas. The mean age was 40.1 (s.d. 12.1 years) and range from
25 to 92 years. The majority of participants were married (79.2%),
most had primary or secondary school education (46.0%). Current
smoking among men were higher than women (32.1 vs 5.1%;
P¼ 0.0001). Overall, 21.3% of the sample had positive family
history of hypertension.
Prevalence of hypertension
Overall, 27.6% of the Palestinian adult population aged 25 years
and over had hypertension, representing 3 33 000 individuals
(Table 2). The overall prevalence of hypertension was higher
among men than among women (29.2 vs 26.4% P¼ 0.01). The
prevalence of hypertension increased with age in both men and
women. Prevalence of hypertension was slightly higher in urban
than in rural areas, but the difference was not signiﬁcant (28.2 and
26.6%, respectively; P¼ 0.08). The rate of hypertension among
smokers (29.2%) was higher than that among non-smokers
(28.4%). However, this difference was not statistically signiﬁcant
(P¼ 0.62).
Awareness, treatment and control of hypertension
Table 3 shows proportions of participants with hypertension who
were aware of their hypertensive condition, were being treated
with antihypertensive drugs, and who were both treated and
controlled. Overall, 51.0% of those with hypertension were aware
of their diagnosis, only 40.2% were taking prescribed medication
to lower their BP, and only 9.5% achieved BP control. One-third
(33.2%) of hypertensives who were being treated, successfully
Table 1. Characteristics of participants (n¼ 2077) in a national sample
survey of hypertension in West Bank, Palestine (2011)
Variable Men, n (%) Women, n (%)
Total 872 (42.0) 1205 (58.0)
Age (years)
25–44 370 (42.5) 467 (38.8)
45–64 391 (44.8) 562 (46.6)
X65 111 (12.7) 176 (14.6)
Residence
Urban 560 (64.2) 765 (63.5)
Rural 312 (35.8) 440 (36.5)
Marital status
Married 707 (81.1) 937 (77.8)
Non-married 165 (18.9) 268 (22.2)
Education
Illiterate 170 (19.5) 270 (22.4)
Primary and secondary school 391 ( 44.8) 563 (46.7)
High school and above 311 (35.7) 372 (30.9)
Family history of hypertension
Absent 681 (78.1) 954 (79.2)
Present 191 (21.9) 251 (20.8)
Smoking status
Smoker 280 (32.1) 61 (5.1)
Non-smoker 458 (52.5) 1059 (87.9)
Ex-smoker 134 (15.4) 85 (7.0)
Weight status
Normal 330 (37.8) 398 (33.0)
Overweight 360 (41.2) 523 (43.4)
Obese 182 (21.0) 284 (23.6)
Table 2. Prevalence of hypertensiona in adult population aged 25
years and over in West Bank, Palestine
Age, years Men, n (%) Women, n (%) Total, n (%)
25–44 63 (17.0) 78 (16.7) 141 (16.8)
45–64 134 (34.3) 155 (27.6) 289 (30.3)
X65 58 (52.3) 85 (48.3) 143 (49.8)
Total 255 (29.2) 318 (26.4) 573 (27.6)
Residence
Urban 167 (29.6) 207 (27.1) 373 (28.2)
Rural 88 (28.2) 112 (25.3) 200 (26.6)
Total 255 (29.2) 318 (26.4) 573 (27.6)
aSBP X140mmHg and/or DBP X90mmHg, and/or taking antihyperten-
sive medication.
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controlled their BP. More than half of the women were aware of
their hypertension, higher than the corresponding value in men
(53.8 vs 39.8%, P¼ 0.01). The prevalence of treatment and control
were higher in women than in men (43.3 vs 36.1%, P¼ 0.02, and
35.9 vs 29.3%, P¼ 0.01, respectively).
Mean BP values
The gender- and age-speciﬁc mean BP levels for the total sample
and for three subgroups deﬁned by hypertension status are
shown in Table 4. Overall, the mean (±s.d.) SBP was
124.7±11.2mmHg and the mean DBP was 77.8±8.2mmHg.
Overall, men had slightly higher SBP and DBP levels than those of
women. Both mean SBP and DBP increased with age throughout
the entire age range. The mean SBP and DBP for normotensive
participants were 24.8 and 12.8mmHg lower than the corre-
sponding ﬁgures for those with treated hypertension, and 27.9
and 15.3mmHg lower than the corresponding ﬁgures for those
with untreated hypertension, respectively. In contrast, individuals
under antihypertensive treatment showed only SBP 3.1mmHg
and DBP 2.5mmHg lower than corresponding values among
individuals without antihypertensive treatment.
Distribution of BP
Table 5 shows the gender- and age-speciﬁc estimates of the
distribution of BP according to the international classiﬁcation
system outlined above. Overall, 53.2% of men and 61.3% of
women had optimal or normal BP (SBP o130mmHg and DBP
o85mmHg), whereas 17.6% of men and 13.1% of women had
high normal BP. The prevalence of stages 1, 2 and 3 hypertension
was 19.1, 6.8 and 3.3% in men, and 17.1, 5.9 and 2.6% in women,
respectively. The proportion of hypertensive men with moderate
or severe BP (for example, grade 2 or grade 3 hypertension with
BPX160/100mmHg) increased from 5.8% in patients aged 25–44
Table 3. Percentage of individuals with hypertension who are aware,
treated and controlled, and Percentage of treated individuals with
hypertension who are controlled in adult population aged X25 years
in West Bank, Palestine
Age, years Hypertensive
Aware Treated Controlleda Controlled treatedb
Men 47.2 (2.1) 36.1 (1.9) 7.6 (2.4) 29.3 (2.1)
25–44 42.1 (3.2) 25.1 (3.6) 8.2 (3.3) 32.1 (4.0)
45–64 49.3 (1.9) 40.2 (3.3) 6.9 (2.8) 28.9 (3.2)
X65 58.2 (3.2) 58.3 (3.8) 7.9 (3.4) 21.5 (2.8)
Women 53.8 (2.4) 43.3 (1.8) 10.8 (1.6) 35.9 (2.4)
25–44 46.9 (3.5) 37.2 (2.1) 12.0 (1.9) 39.2 (3.8)
45–64 53.6 (2.9) 46.1 (2.7) 9.9 (2.2) 34.1 (3.3)
X65 79.1 (2.8) 54.9 (3.1) 9.8 (2.4) 30.7 (2.8)
Total 51.0 (1.6) 40.2 (1.3) 9.5 (1.2) 33.2 (1.8)
Values are % (s.e.).
aThis is the proportion of hypertensives with SBP 4140mmHg and
DBP490mmHg. bThis is the proportion of hypertensives on an antihyperten-
sive medication with systolic BP o140mmHg and diastolic BP o90mmHg.
Table 4. Mean (s.d.) of SBP and DBP (mmHg) in a Palestinian adult population aged X25 years, by age and sex
Age, years Normotensive Treated hypertensive Untreated hypertensive Mean BP in the entire populationa
SBP DBP SBP DBP SBP DBP SBP DBP
Total 121.4 (9.0) 75.9 (6.7) 146.2 (8.8) 88.7 (6.7) 149.3 (9.8) 91.2 (6.4) 124.7 (11.2) 77.8 (8.2)
25–44 118.1 (10.4) 75.9 (8.8) 145.0 (12.1) 87.8 (7.6) 147.2 (10.3) 92.2 (7.7) 120.5 (10.7) 76.7 (7.8)
45–64 122.7 (10.1) 76.7 (6.7) 147.1 (10.3) 90.1 (6.4) 149.2 (11.1) 91.5 (8.0) 126.2 (11.3) 78.7 (9.0)
X65 126.7 (09.2) 73.2 (8.8) 152.3 (10.8) 88.9 (9.0) 156.1 (10.3) 90.2 (8.2) 138.0 (10.9) 78.8 (6.9)
Men 124.6 (9.9) 77.1 (7.5) 147.8 (10.0) 89.9 (6.6) 149.9 (9.9) 92.2 (7.5) 126.8 (8.5) 79.9 (7.1)
25–44 120.2 (11.1) 76.1 (8.7) 145.8 (10.6) 88.9 (7.8) 147.9 (11.4) 92.9 (7.8) 121.4 (10.5) 78.8 (8.1)
45–64 127.3 (12.1) 78.7 (7.9) 148.7 (11.2) 90.6 (9.4) 150.2 (10.8) 92.7 (8.9) 129.7 (11.0) 80.1 (9.0)
X65 129.1 (10.8) 76.6 (9.5) 153.5 (10.5) 90.5 (9.0) 156.1 (10.9) 88.5 (8.8) 137.7 (10.9) 79.0 (7.8)
Women 119.1 (9.4) 75.1 (7.8) 145.0 (9.2) 87.8 (9.1) 148.8 (8.7) 90.1 (6.9) 123.2 (9.3) 75.6 (7.6)
25–44 116.8 (10.6) 74.3 (9.8) 143.1 (10.1) 86.9 (9.2) 146.3 (9.91) 92.4 (7.9) 119.4 (10.9) 75.1 (8.2)
44–64 119.5 (11.2) 75.9 (7.9) 146.0 (11.1) 88.9 (8.7) 149.6 (11.3) 91.3 (8.4) 124.8 (10.1) 76.5 (8.0)
X65 124.0 (10.7) 74.8 (9.1) 151.5 (10.9) 86.8 (9.3) 155.5 (10.4) 89.3 (7.0) 132.3 (11.4) 79.6 (8.1)
Abbreviations: DBP, diastolic blood pressure; SBP, systolic blood pressure Values are mean (s.d.).
aMean BP levels in the entire population age 25þ (irrespective of treatment status), and according to age and gender.
Table 5. Percentage distribution of BP levelsa in adult population,
aged 25 years and over, in West Bank, Palestine by age and gender
Age, years Optimal Normal High
normal
Stage 1 Stage 2 Stage 3
SBP
(mm Hg)
4120 4130 130–139 140–59 160–179 X180
DBP
(mm Hg)
480 485 85–89 90–99 100–109 X110
Prevalence
in the
entire
population
35.6 22.4 15.2 17.9 6.1 2.8
Men 31.3 21.9 17.6 19.1 6.8 3.3
25–44 41.2 25.6 15.5 11.9 4.9 0.9
45–64 23.1 21.1 19.3 24.3 7.6 4.6
X65 22.2 13.5 18.8 27.8 10.6 7.1
Women 39.3 22 13.1 17.1 5.9 2.6
25–44 50.5 24.1 11.7 9.8 3.4 0.6
45–64 33.4 21.8 16.5 18.3 6.6 3.4
X65 22.1 20.6 18.3 23.4 11.1 4.5
Values are % (s.d.). Rows may not be total 100% because of rounding.
aBased on categories established in the sixth report of the Joint National
Committee on Detection, Evaluation and treatment of high blood pressure.
# prevalence in the entire population.
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years to 12.2% in patients over 44–64 years. The proportion of
women with grades 2–3 hypertension remained lower in the same
age groups.
Factors associated with hypertension prevalence
Multivariable logistic models were constructed to further analyze
the association of hypertension and sociogeographical factors
separately among men and women. Any variables identiﬁed as
tending to signiﬁcance during the univariable analysis were
included in the multivariable logistic regression analysis. After
adjustment for age, sex and residency (urban/rural), the odds for
hypertension increased with age and were statistically higher in all
age groups compared with the 25–44 age group. As shown in
Table 6, having family histories of hypertension, being overweight
or obese were signiﬁcantly associated with hypertension for both
men and women. The association between hypertension and
variables of residency, education and marital status was found to
be not signiﬁcant.
DISCUSSION
The present study provides the ﬁrst data on the distribution of
hypertension in West Bank, Palestine that have experienced a
rapid cultural transition during the last three decades. This study
was conducted in a representative sample of the Palestinian adult
population using standard protocols and instruments with strong
quality control procedures for measurement of BP, and collection
of a wide array of sociogeographical characteristics to ensure the
quality of the data collection.
This study found that hypertension affects more than a quarter
of the adult population, amounting toB3 33 000 people. A similar
pattern was reported from other developed and developing
countries.17–23 This shows that the global burden of hypertension
is considerable, and it appears to be increasing, which is a cause
for concern for health and other concerned authorities. This
requires an urgent intervention plan. This study showed the
signiﬁcant relation of hypertension with advancing age in both
sexes in agreement with international studies.24,25 Approximately
41% of individuals above the age of 60 years suffer from
hypertension. This indicates the degenerative aging process,
resulting in thickening and loss of elasticity of arteries, which is a
contributing factor for high BP.26
The higher prevalence of hypertension in men than women in
this study appears to be in agreement with some national and
regional studies.17,20,21 Overall, worldwide prevalence of hyper-
tension, however, showed no signiﬁcant gender difference.26
Reported gender differences may result from biological
differences, but they may be due to other sociodemographic,
comorbidity and obesity confounding effect.
Our ﬁndings showed the prevalence of hypertension was
slightly higher in urban than in rural areas, but the difference was
not signiﬁcant. The central region is highly urbanized, industria-
lized and developed compared with the southern and northern
regions. Geographical variations in the prevalence of hypertension
were reported by many studies in different regions of the
world.17,27–29 These regional variations in BP may also be related
to variation in socioeconomic, demographic and dietary
characteristics, in addition to the geographic ones.
The percentage of awareness, treatment and control of
hypertension is low in the Palestinian adult population. Approxi-
mately 51% of the hypertensive patients were aware of their disease
at the time of the survey in agreement with a previous study.30
Higher awareness of hypertension in this study was signiﬁcantly
more among females, older people and residents of urban region. In
other countries, a quarter to more than half of hypertensives were
unaware of their disease, and in some developing countries a
devastating 85% unawareness rate was reported.31–34
In general, the present study found that control of hypertension
is limited to one-third (33.2%) among the individuals ever
diagnosed with the condition. Control of hypertension is
signiﬁcantly higher among women rather than men, among the
residents of urban rather than those of rural areas, and it increases
with age. These may be the expected ﬁndings, as younger
individuals usually suffer less comorbidity, which may facilitate
hypertension control. Female subjects may be more concerned
with their health status. Even more problematic, this study found
practically no difference in mean BP between treated and
untreated hypertensives. Individuals under antihypertensive
treatment showed only SBP 3.1mmHg and DBP 2.5mmHg lower
than corresponding values among untreated hypertensives. In
contrast, US survey35 had found 9/5mmHg reduction in mean BP
on treatment overall, and the difference found in a Belgian survey
was 12/13mmHg.36
Consistent with the ﬁndings of other studies, our data showed a
higher rate of hypertension among subjects with positive family
history of this disease than their counterparts. Havlik37 in his
review concluded that about one-third to one-half of the
variability in BP is explained by genetics. In agreement with
other studies,2,13–15 the obese group appeared to have a higher
risk of hypertension than the non-obese group, after adjusting for
other potential cofounders. Inconsistent with the ﬁnding of other
studies, our data failed to show a signiﬁcant relationship between
hypertension and living area (urban/rural) and education level. It is
important to note though that being non-signiﬁcant does not
necessarily mean that the relationship does not exist. It could be
the case that our sample sizes did not have enough power to
detect some relationships.
Table 6. Multiple logistic regression showing factors associated with
prevalence of hypertension in Palestinian population, by sex
Variables Males Females
OR (95% CI)a P-
value
OR (95% CI)a P-
value
Age group
25–44 1:00 1:00
45–64 2:34 (1.10–5.56) 0.001 2.13 (0.98–3.36) 0.001
X65 3.61 (1.27–8.10) 0.001 3.21 (1.1–1.44) 0.001
Residence
Rural 1:00 1:00
Urban 1.11 (0.86–1.58) 0.10 1.23 (0.91–1.48) 0.12
Marital status
Married 1:00 1:00
Non-married 0.95 (0.79–1.44) 0.43 1.1 (0.88–1.58) 0.62
Family history
Absent 1:00 1:00
Present 1.82 (1.10- 2.23) 0.001 2.13 (1.70–3.00) 0.001
Education
Illiterate 1:00 1:00
Primary and
secondary school
1.22 (0.99–1.77) 0.10 1.12 (0.87–1.23) 0.10
High school and
above
1.43 (1.13–1.91) 0.08 1.32 (0.71–1.2) 0.07
Weight status
Normal 1:00 1:00
Overweight 2.20 (1.64–3.42) 0.001 3.11 (1.99–3.66) 0.001
Obese 2.99 (1.17–4.37) 0.001 3.51 (2.10–4.81) 0.001
Abbreviations: CI, confidence interval; OR, odds ratio.
aOR, adjusted for age, sex, urban/rural.
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These observations should encourage the development of
national campaigns in order to increase public awareness, and
should alert the health planners to start prevention programs and
improve physicians’ education and training. In countries with
national health programs effectuated for cardiovascular risk
reduction, the level of BP awareness has much improved, rising
to 66% in United Kingdom38 or 76% in United States,39 and
attesting the success of a coordinated policy for high BP detection.
Limitations
The diagnostic criteria recommended by the Joint National
Committee 12 required BP measurements at two or more
subsequent visits after an initial screen. It is clearly difﬁcult to
use such criteria to diagnose hypertension in large population
surveys. Therefore, the prevalence of hypertension in this survey
may have been overestimated. In addition, the percentage of
treated hypertensives whos’ BP were controlled may be
underestimated.
CONCLUSION
The present study found that hypertension affects more than a
quarter of the adult population, less than half of them were
unaware of their disease and only one-third of those under drug
treatment were controlled, as judged by their BP measurement of
o140/90mmHg. Despite the availability of a large number of
effective and well-tolerated antihypertensive drugs and other
modalities, BP control rates are not satisfactory on a national and
global scale.
The high prevalence of hypertension coupled with low
proportions of awareness, treatment and control has important
implications for public health staff, physicians, health-care
providers and health policy decision makers in Palestine. Health-
care provider should start comprehensive programs to increase
public awareness and to combat the hypertension problem.
Special attention will be given to groups most affected and those
least aware or treated.
What is known about the topic
 Global burden of hypertension is considerable, and it appears to be
increasing, which is a cause for concern for health and other
concerned authorities.
What this study adds
 Only one-half of the hypertensives were aware of their disease at the
time of the survey.
 Awareness of hypertension were more associated with females, older
people and residents of urban region.
 The percentage of treatment and control of hypertension is low in the
Palestinian adult population.
 Efforts to combat the hypertension problem should be comprehen-
sive, including all sectors of the community.
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